Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline
Friday, October 21, 2022AbbVie announced the acquisition of DJS Antibodies Ltd DJS a privatelyheld UKbased biotechnology company dedicated to discovering and developing antibody medicines that target difficulttodrug diseasecausing proteins such as G proteincoupled receptors...
Amgen Successfully Completes Acquisition of Chemocentryx
Friday, October 21, 2022Amgen announced that it has successfully completed its previously announced acquisition of ChemoCentryx Inc a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune diseases inflammatory disorders and cancer for pe...
Ginkgo Bioworks Completes Acquisition of Zymergen
Thursday, October 20, 2022Ginkgo Bioworks the leading horizontal platform for cell programming and Zymergen Nasdaq ZY announced that Ginkgo has completed its previously announced acquisition of Zymergen The acquisition is expected to significantly enhance Ginkgos platform by...
Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp® DBC instrument
Thursday, October 20, 2022Telesis Bio a leader in automated multiomic and synthetic biology solutions and Cellibre a leading manufacturing technology company today announced initiation of work under a collaboration to optimize the development and validation of Telesis Bios Bi...
Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss
Wednesday, October 19, 2022Eli Lilly and Company and Akouos Inc today announced a definitive agreement for Lilly to acquire Akouos a precision genetic medicine company that is developing a portfolio of firstinclass adenoassociated viral gene therapies for the treatment of inne...
Verseon Acquires Edammo
Wednesday, October 19, 2022Verseon International Corporation the company leading a technologydriven transformation of the pharmaceutical industry announces that it has acquired Edammo Inc Verseon has spent much of the past two decades pioneering scientific advances in molecula...
Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies
Tuesday, October 18, 2022Gilead Sciences Inc and MacroGenics today announced an exclusive option and collaboration agreement to develop MGD an investigational bispecific antibody that binds CD and CD using MacroGenics DART platform and two additional bispecific research prog...
Immune-Onc Therapeutics Initiates Expansion Cohorts for IO-108 and Enters into Clinical Supply Agreement with Regeneron
Tuesday, October 18, 2022ImmuneOnc Therapeutics Inc a private clinicalstage cancer immunotherapy company developing novel biotherapeutics targeting myeloid checkpoints today announced the dosing of the first patient in the expansion cohorts of its ongoing Phase study for IO...
ImaginAb and Cyclotek Enter into Manufacturing and Distribution Agreement for CD8 ImmunoPET Agent in Australia
Monday, October 17, 2022ImaginAb Inc a global biotechnology company focused on developing Zr crefmirlimab berdoxam CD ImmunoPET imaging agent and radiopharmaceutical therapies RPT products is pleased to announce the completion of a Master Services Agreement with Cyclotek a...
Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies
Friday, October 14, 2022Xcell Biosciences Inc an instrumentation company focused on cell and gene therapy applications and aCGT Vector a pointofcare cell and gene therapyasaservice TaaS company today announced a collaboration to improve manufacturing and analytic procedures...
